Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential Hypertension
Clinical trial NCT01788358 · COMPLETED
Trial details
- NCT number
- NCT01788358
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-14
- Primary completion
- 2014-05-01
- Enrollment
- 508
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.